The disinfection cap industry share is estimated to clock a revenue of US$ 376.8 million in 2024. Key players of the disinfection cap can expect a modest CAGR of 4.5% through 2034, with a forecast valuation of US$ 585.1 million by 2034.
Healthcare-acquired infections (HAIs) affect millions of people annually, contributing to considerable healthcare costs. To reduce these expenses, healthcare providers are extensively deploying disinfection caps. Moreover, the elderly population is at a higher risk of acquiring these infections due to their weakened immune systems. Therefore, countries dense with geriatric populations are more likely to invest heavily in sterile cap solutions to protect their citizens from HAIs.
New technological advancements in disinfection caps to match the current requirements of healthcare professionals are anticipated to raise the market value. Recent developments include needleless caps, antimicrobial coatings, and extended dwell caps.
| Attributes | Key Statistics |
|---|---|
| Expected Base Year Value (2024) | US$ 376.8 million |
| Market Size (2034) | US$ 585.1 million |
| Estimated Growth (2024 to 2034) | 4.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Attributes | Details |
|---|---|
| Disinfection Cap Market Size (2019) | US$ 315.7 million |
| Disinfection Cap Market Value (2023) | US$ 369.3 million |
| Historical Growth Rate % (2019 to 2023) | 4% |
The disinfection cap market extrapolated from US$ 315.7 million in 2019 to US$ 369.3 million in 2023. Meanwhile, the market experienced a CAGR of 4%. Top factors that have been fueling the sales of disinfection caps are as follows:
Disinfection cap sales are projected to swing up from US$ 376.8 million in 2024 to US$ 585.1 million by 2034. FMI analysts have estimated that the market is anticipated to observe a CAGR of 4.5% throughout this period. An increase in CAGR over the forecast period indicates that the market is anticipated to flourish in upcoming years.
The rise in global population, lifestyle changes, and surging hospitalizations are, in combination, projected to increase the market value. Core factors raising the disinfection cap market value are mentioned below:
| Historical CAGR % (2019 to 2023) | 4% |
|---|---|
| Forecast CAGR % (2024 to 2034) | 4.5% |
Principal Consultant
| Country | The United States |
|---|---|
| Forecast CAGR % (2024 to 2034) | 4.1% |
The United States disinfection cap market holds a prominent position in North America as well as internationally. As per the latest market estimates, the country is set to expand at a CAGR of 4.10% through 2034. Crucial factors raising the sales of disinfection caps are as follows:
| Country | Germany |
|---|---|
| Forecast CAGR % (2024 to 2034) | 3.6% |
Germany is projected to be an important market for disinfection caps in Europe. The country is set to accelerate through the forecast period at a 3.6% CAGR. Given below are the leading components that are driving the German market:
| Country | China |
|---|---|
| Forecast CAGR % (2024 to 2034) | 5.5% |
In China, the disinfection cap market is projected to expand at a greater rate of 5.5% CAGR than its counterparts. This can be attributed to the considerable and rapidly growing population as well as medical incidences in the country. As a result, manufacturers are scouting for opportunities in China. Other factors that are consolidating China’s position on a global scale are as follows:
| Country | India |
|---|---|
| Forecast CAGR % (2024 to 2034) | 4.9% |
India is projected to emerge as a steadfast player in the overall disinfection cap market. As per analysis, the market is projected to be driven at a 4.9% CAGR through 2034. Players are traversing boundaries to possess a larger consumer base. Other factors increasing the sales of medical disinfection caps are as follows:
| Country | Australia |
|---|---|
| Forecast CAGR % (2024 to 2034) | 4.60% |
Australia is forecast to expand at a CAGR of 4.60% through 2034. Key factors pulling the market’s growth are listed below:
| Leading End Use | Hospitals |
|---|---|
| Value Share % (2024) | 38.80% |
The hospital segment is projected to acquire a prominent market share of 38.80% in 2024. Considerable patient footfall in hospitals is raising the share of this segment in the disinfection cap market. Increasing utilization of intravenous connectors and catheters for multiple purposes like blood transfusion, parenteral nutrition, dialysis, etc., is pushing product demand. Additionally, mounting healthcare expenditure to develop more hospitals is favoring sales of disinfection caps.
| Leading Distribution Channel | Non-retail |
|---|---|
| Value Share % (2024) | 63.80% |
The non-retail segment is anticipated to obtain a 63.80% share of the global market in 2024. Non-retail distribution of disinfection caps has become a norm as hospitals and clinics usually come into long-term contracts and alliances with distributors and manufacturers. The rising count of group purchasing organizations (GPOs) that accumulate purchasing power of multiple healthcare facilities is also contributing to this segment's growth. This gives them bargaining power to negotiate a lower price for disinfection caps with manufacturers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Market leaders in the disinfection cap industry are zeroing in on organic growth tactics like new product developments and product approvals. These steps are expected to forward participants' revenue and clientele in the disinfection cap market. Market distributors are deploying their resources to lead to innovations in disinfection cap technology. The widened product portfolio is anticipated to raise companies' revenue generation.
Disinfection cap players ceaselessly invest in research and development to advance the market's growth. Inorganic growth strategies employed by players include acquisitions, collaborations, and partnerships.
Key Developments Favoring the Growth of the Disinfection Cap Market
| Company Name | Company Particulars |
|---|---|
| 3M Company | It is an American MNC that works in the fields of healthcare, worker safety, and consumer goods. The company has a culture of innovation and applies science to life. The company caters to numerous industries, such as automotive, health care, electronics, consumer markets, etc. |
| Becton Dickinson and Company | It is a global med-tech company. The company is advancing the world of health by launching innovative technology, solutions, and services for healthcare practitioners and patients. |
| ICU Medical Inc. | It is a California-based company that operates globally. The company designs products aiming to prevent bloodstream infections and safeguard healthcare workers from exposure to hazardous drugs or infectious diseases. |
| B. Braun Melsungen AG | B. Braun Melsungen AG is a German company that delivers medical and pharmaceutical devices. Presently, the company has over 63,000 employees internationally, with production facilities and offices in over 60 countries. |
| Baxter International Inc. | It is a healthcare MNC with headquarters in Deerfield, Illinois. The firm focuses on products that treat kidney diseases and other acute and chronic medical conditions. The company is pursuing healthcare transformation to help providers and patients beat the challenges they face. |
The disinfection cap market is expected to be worth US$ 376.8 million in 2024.
The market is predicted to expand at a CAGR of 4.5% through 2034.
The market is anticipated to account for US$ 585.1 million by 2034.
China is predicted to provide high growth opportunities.
Hospitals acquire a leading share, with an estimated share of 38.80% in 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2024 to 2034
5.3.1. Non-retail
5.3.2. Retail
5.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Distribution Channel
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Distribution Channel
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Distribution Channel
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Distribution Channel
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Distribution Channel
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Distribution Channel
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Distribution Channel
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Distribution Channel
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Distribution Channel
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Distribution Channel
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Distribution Channel
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Distribution Channel
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Distribution Channel
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Distribution Channel
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2023
15.1.2.1. By Distribution Channel
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2023
15.2.2.1. By Distribution Channel
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2023
15.3.2.1. By Distribution Channel
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2023
15.4.2.1. By Distribution Channel
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2023
15.5.2.1. By Distribution Channel
15.5.2.2. By End User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2023
15.6.2.1. By Distribution Channel
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2023
15.7.2.1. By Distribution Channel
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2023
15.8.2.1. By Distribution Channel
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2023
15.9.2.1. By Distribution Channel
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2023
15.10.2.1. By Distribution Channel
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2023
15.11.2.1. By Distribution Channel
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2023
15.12.2.1. By Distribution Channel
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2023
15.13.2.1. By Distribution Channel
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2023
15.14.2.1. By Distribution Channel
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2023
15.15.2.1. By Distribution Channel
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2023
15.16.2.1. By Distribution Channel
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2023
15.17.2.1. By Distribution Channel
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2023
15.18.2.1. By Distribution Channel
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2023
15.19.2.1. By Distribution Channel
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2023
15.20.2.1. By Distribution Channel
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2023
15.21.2.1. By Distribution Channel
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2023
15.22.2.1. By Distribution Channel
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2023
15.23.2.1. By Distribution Channel
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Distribution Channel
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Becton, Dickinson and Company
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. 3M Company
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. ICU Medical
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Merit Medical
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Agilent Technologies, Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. B. Braun Melsungen AG
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Thermo Fisher Scientific, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Biocrates Life Sciences AG
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Excelsior Medical LLC
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Henry Schein
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. JCM MED
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Chemicals & Materials
April 2023
REP-GB-17014
423 pages
Explore Consumer Product Insights
View Reports
Disinfection Cap Market
